2246 related articles for article (PubMed ID: 8297135)
21. Molecular cloning of a human monoclonal antibody reactive to ganglioside GM3 antigen on human cancers.
Hoon DS; Wang Y; Sze L; Kanda H; Watanabe T; Morrison SL; Morton DL; Irie RF
Cancer Res; 1993 Nov; 53(21):5244-50. PubMed ID: 7916649
[TBL] [Abstract][Full Text] [Related]
22. Demonstration of monoclonal anti-carcinoembryonic antigen (CEA) antibody internalization by electron microscopy, western blotting and radioimmunoassay.
Tsaltas G; Ford CH; Gallant M
Anticancer Res; 1992; 12(6B):2133-42. PubMed ID: 1295459
[TBL] [Abstract][Full Text] [Related]
23. Five new epitope-defined monoclonal antibodies reactive with GM2 and human glioma and medulloblastoma cell lines.
Vrionis FD; Wikstrand CJ; Fredman P; Månsson JE; Svennerholm L; Bigner DD
Cancer Res; 1989 Dec; 49(23):6645-51. PubMed ID: 2479468
[TBL] [Abstract][Full Text] [Related]
24. Compartmental distribution of tumor-specific monoclonal antibodies in human melanoma xenografts.
Lin K; Nagy JA; Xu H; Shockley TR; Yarmush ML; Dvorak HF
Cancer Res; 1994 Apr; 54(8):2269-77. PubMed ID: 8174137
[TBL] [Abstract][Full Text] [Related]
25. Chimeric and humanized anti-HM1.24 antibodies mediate antibody-dependent cellular cytotoxicity against lung cancer cells.
Wang W; Nishioka Y; Ozaki S; Jalili A; Verma VK; Hanibuchi M; Abe S; Minakuchi K; Matsumoto T; Sone S
Lung Cancer; 2009 Jan; 63(1):23-31. PubMed ID: 18524412
[TBL] [Abstract][Full Text] [Related]
26. Disialoganglioside GD2 on human neuroblastoma cells: target antigen for monoclonal antibody-mediated cytolysis and suppression of tumor growth.
Mujoo K; Cheresh DA; Yang HM; Reisfeld RA
Cancer Res; 1987 Feb; 47(4):1098-104. PubMed ID: 3100030
[TBL] [Abstract][Full Text] [Related]
27. Immunotherapeutic strategies in neuroblastoma: antitumoral activity of deglycosylated Ricin A conjugated anti-GD2 antibodies and anti-CD3xanti-GD2 bispecific antibodies.
Manzke O; Russello O; Leenen C; Diehl V; Bohlen H; Berthold F
Med Pediatr Oncol; 2001 Jan; 36(1):185-9. PubMed ID: 11464879
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibodies to disialogangliosides: characterization of antibody-mediated cytotoxicity against human melanoma and neuroblastoma cells in vitro.
Kawashima I; Tada N; Fujimori T; Tai T
J Biochem; 1990 Jul; 108(1):109-15. PubMed ID: 2121721
[TBL] [Abstract][Full Text] [Related]
29. Light chain variants of an IgG3 anti-GD3 monoclonal antibody and the relationship among avidity, effector functions, tumor targeting, and antitumor activity.
Chapman PB; Lonberg M; Houghton AN
Cancer Res; 1990 Mar; 50(5):1503-9. PubMed ID: 2105840
[TBL] [Abstract][Full Text] [Related]
30. The GD2-specific 14G2a monoclonal antibody induces apoptosis and enhances cytotoxicity of chemotherapeutic drugs in IMR-32 human neuroblastoma cells.
Kowalczyk A; Gil M; Horwacik I; Odrowaz Z; Kozbor D; Rokita H
Cancer Lett; 2009 Aug; 281(2):171-82. PubMed ID: 19339105
[TBL] [Abstract][Full Text] [Related]
31. DNA vaccine expressing the mimotope of GD2 ganglioside induces protective GD2 cross-reactive antibody responses.
Bolesta E; Kowalczyk A; Wierzbicki A; Rotkiewicz P; Bambach B; Tsao CY; Horwacik I; Kolinski A; Rokita H; Brecher M; Wang X; Ferrone S; Kozbor D
Cancer Res; 2005 Apr; 65(8):3410-8. PubMed ID: 15833876
[TBL] [Abstract][Full Text] [Related]
32. Two human monoclonal antibodies reacting with the major gangliosides of human melanomas and comparison with corresponding mouse monoclonal antibodies.
Furukawa K; Yamaguchi H; Oettgen HF; Old LJ; Lloyd KO
Cancer Res; 1989 Jan; 49(1):191-6. PubMed ID: 2908845
[TBL] [Abstract][Full Text] [Related]
33. In vitro and in vivo targeting properties of iodine-123- or iodine-131-labeled monoclonal antibody 14C5 in a non-small cell lung cancer and colon carcinoma model.
Burvenich I; Schoonooghe S; Cornelissen B; Blanckaert P; Coene E; Cuvelier C; Mertens N; Slegers G
Clin Cancer Res; 2005 Oct; 11(20):7288-96. PubMed ID: 16243799
[TBL] [Abstract][Full Text] [Related]
34. Glycosylation pathways in the biosynthesis of gangliosides in melanoma and neuroblastoma cells: relative glycosyltransferase levels determine ganglioside patterns.
Ruan S; Lloyd KO
Cancer Res; 1992 Oct; 52(20):5725-31. PubMed ID: 1394196
[TBL] [Abstract][Full Text] [Related]
35. Characterization of an Ig VH idiotope that results in specific homophilic binding and increased avidity for antigen.
Yan X; Evans SV; Kaminki MJ; Gillies SD; Reisfeld RA; Houghton AN; Chapman PB
J Immunol; 1996 Aug; 157(4):1582-8. PubMed ID: 8759742
[TBL] [Abstract][Full Text] [Related]
36. Spatial distribution of tumor-specific monoclonal antibodies in human melanoma xenografts.
Shockley TR; Lin K; Nagy JA; Tompkins RG; Yarmush ML; Dvorak HF
Cancer Res; 1992 Jan; 52(2):367-76. PubMed ID: 1728408
[TBL] [Abstract][Full Text] [Related]
37. Augmented binding of radiolabeled monoclonal antibodies to melanoma cells using specific antibody combinations.
Mujoo K; Rosenblum MG; Murray JL
Cancer Res; 1991 Jun; 51(11):2768-72. PubMed ID: 2032216
[TBL] [Abstract][Full Text] [Related]
38. Tumor pretargeting: role of avidin/streptavidin on monoclonal antibody internalization.
Casalini P; Luison E; Ménard S; Colnaghi MI; Paganelli G; Canevari S
J Nucl Med; 1997 Sep; 38(9):1378-81. PubMed ID: 9293791
[TBL] [Abstract][Full Text] [Related]
39. Human IgG3 monoclonal antibody directed to an unbranched repeating type 2 chain (Gal beta 1----4GlcNAc beta 1----3Gal beta 1----4GlcNAc beta 1----3Gal beta 1----R) which is highly expressed in colonic and hepatocellular carcinoma.
Miyake M; Kohno N; Nudelman ED; Hakomori S
Cancer Res; 1989 Oct; 49(20):5689-95. PubMed ID: 2551493
[TBL] [Abstract][Full Text] [Related]
40. Density-dependent recognition of cell surface GM3 by a certain anti-melanoma antibody, and GM3 lactone as a possible immunogen: requirements for tumor-associated antigen and immunogen.
Nores GA; Dohi T; Taniguchi M; Hakomori S
J Immunol; 1987 Nov; 139(9):3171-6. PubMed ID: 3668254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]